{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Candel Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"CADL"},"Address":{"label":"Address","value":"117 KENDRICK STREET,SUITE 450, NEEDHAM, Massachusetts, 02494, United States"},"Phone":{"label":"Phone","value":"+1 617 916-5445"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies."},"CompanyUrl":{"label":"Company Url","value":"https://www.candeltx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Francesca Barone","title":"Chief Scientific Officer"},{"name":"Paul-Peter Tak","title":"President, Chief Executive Officer & Director"},{"name":"Seshu Tyagarajan","title":"Chief Technical & Development Officer"},{"name":"William Garrett Nichols","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}